Your browser doesn't support javascript.
loading
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities.
Cooksley, Tim; Girotra, Monica; Ginex, Pamela; Gordon, Ruth Ann; Anderson, Ronald; Blidner, Ada; Choi, Jennifer; Dougan, Michael; Glezerman, Ilya; Gupta, Dipti; Johnson, Douglas; Shannon, Vickie R; Suarez-Almazor, Maria; Rapoport, Bernardo L.
Afiliación
  • Cooksley T; The Christie and Manchester University Foundation Trust, Manchester, UK.
  • Girotra M; Department of Medicine, Endocrine Division, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Ginex P; Weill Cornell Medical College, New York, NY, USA.
  • Gordon RA; Oncology Nursing Society, Pittsburgh, PA, USA.
  • Anderson R; Clinical Trials, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Blidner A; Department of Immunology, Faculty of Health Sciences, University or Pretoria, Corner Doctor Savage Road and Bophelo Road, Pretoria, 0002, South Africa.
  • Choi J; Laboratory of Immunopathology, Institute of Biology and Experimental Medicine-CONICET, Buenos Aires, Argentina.
  • Dougan M; Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Glezerman I; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Gupta D; Renal Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Johnson D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shannon VR; Department of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA.
  • Suarez-Almazor M; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rapoport BL; Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Support Care Cancer ; 28(12): 6175-6181, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32856213
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rol del Médico / Enfermedades del Sistema Endocrino / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rol del Médico / Enfermedades del Sistema Endocrino / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido